thiophenes has been researched along with Psychotic Disorders in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Ronchi, D; Fabbri, C; Fanelli, G; Lippi, M; Serretti, A | 1 |
| Aoki, S; Shimizu, H; Takeda, T; Washida, K; Yamashita, R; Yoshimura, Y | 1 |
| Cannavò, D; Caraci, F; Caruso, G; Drago, F; Leggio, GM; Salomone, S; Santagati, M | 1 |
| Chang, HA; Chiao, HY; Huang, YC; Kung, FH; Lin, HY; Tai, YM; Tzeng, NS | 1 |
| Chang, JP; Chi, MH; Chiu, YN; Gau, SS; Shang, CY; Tsai, WC | 1 |
| D'Arrigo, C; Micò, U; Muscatello, MR; Santoro, V; Spina, E; Zoccali, R | 1 |
| Deuschle, M; Knopf, U; Kuwilsky, A; Mase, E; Zink, M | 1 |
| de Dios, C; Ezquiaga, E | 1 |
| Standal, JE | 1 |
| Butler, R; Christopher, WL; Cipollina, JA; New, JS; Schlemmer, RF; VanderMaelen, CP; Yevich, JP | 1 |
2 review(s) available for thiophenes and Psychotic Disorders
| Article | Year |
|---|---|
The dilemma of polypharmacy in psychosis: is it worth combining partial and full dopamine modulation?
Topics: Antipsychotic Agents; Aripiprazole; Dopamine; Dopamine Agonists; Dopamine Antagonists; Humans; Polypharmacy; Psychotic Disorders; Quinolones; Thiophenes | 2022 |
New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer's disease: focus on brexpiprazole and pimavanserin.
Topics: Alzheimer Disease; Antipsychotic Agents; Anxiety; Humans; Piperidines; Psychotic Disorders; Quinolones; Thiophenes; Urea | 2020 |
1 trial(s) available for thiophenes and Psychotic Disorders
| Article | Year |
|---|---|
Pizotifen as an antidepressant.
Topics: Acute Disease; Adjustment Disorders; Chronic Disease; Clinical Trials as Topic; Depression; Double-Blind Method; Female; Humans; Male; Pizotyline; Psychotic Disorders; Thiophenes | 1977 |
7 other study(ies) available for thiophenes and Psychotic Disorders
| Article | Year |
|---|---|
Association between previous high-dose antipsychotic therapy and brexpiprazole discontinuation after the initiation of brexpiprazole in patients with schizophrenia or schizoaffective disorder.
Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Psychotic Disorders; Quinolones; Retrospective Studies; Schizophrenia; Serotonin Agents; Thiophenes; Withholding Treatment | 2020 |
Brexpiprazole in the Treatment of Cannabis Withdrawal Psychotic Disorder.
Topics: Cannabis; Humans; Psychotic Disorders; Quinolones; Thiophenes | 2022 |
Serotonin-norepinephrine reuptake inhibitor-associated mixed episode in an adolescent with schizoaffective disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Bipolar Disorder; Depressive Disorder; Duloxetine Hydrochloride; Female; Humans; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2014 |
Effect of adjunctive duloxetine on the plasma concentrations of clozapine, olanzapine, and risperidone in patients with psychotic disorders.
Topics: Adult; Benzodiazepines; Clozapine; Drug Interactions; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Olanzapine; Psychotic Disorders; Risperidone; Thiophenes; Young Adult | 2010 |
Duloxetine treatment of major depressive episodes in the course of psychotic disorders.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Personality Inventory; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiophenes; Treatment Outcome | 2006 |
Manic switching in patients receiving duloxetine.
Topics: Adrenergic Uptake Inhibitors; Adult; Bipolar Disorder; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Thiophenes | 2007 |
The thieno[3,2-c]pyridine and furo[3,2-c]pyridine rings: new pharmacophores with potential antipsychotic activity.
Topics: Amphetamines; Animals; Avoidance Learning; Binding, Competitive; Catalepsy; Chemical Phenomena; Chemistry; Dioxanes; Female; Furans; Macaca; Male; Mice; Molecular Structure; Motor Activity; Piperazines; Psychoses, Substance-Induced; Psychotic Disorders; Pyridines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Serotonin; Spiperone; Stereotyped Behavior; Structure-Activity Relationship; Thiophenes | 1989 |